Data as of 12:29pm ET
| -0.24 / -2.71%|
The 4 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 9.50. The median estimate represents a +50.64% increase from the last price of 8.63.
The current consensus among 4 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.